ECAT Foundation

Name

ECAT Foundation

Legal name

ECAT Foundation

Website

https://ecat.nl

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

External Quality Assessment Services

NAICS

Medical Laboratories (621511), Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)

akta.pro primary industry

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)

akta.pro secondary industry

Conformity Assessment, Testing, Inspection & Certification Cooperation (BPADANAD)

Keywords

• External quality assessment
• Laboratory quality control
• Coagulation testing services
• Haemostasis diagnostics
• Point-of-care testing

Headquarters

HQ city

Voorschoten

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. EQA Programme Subscriptions: Annual subscription fees for laboratories participating in the External Quality Assessment Programme, which includes survey materials, result submission access, and survey reports.
2. POCT QC Kit Sales: One-time purchase of INR Quality Control kits for CoaguChek monitors. Single kits priced at €91 per set plus shipping. Also available as annual programme with 4 surveys per year.
3. Symposium Registration: Registration fees for educational symposium events on thrombosis and haemostasis. Pre-symposium at €125, one-day symposium at €175, two-day symposium at €250, plus optional dinner at €67.50.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

ECAT Foundation operates an international External Quality Assessment Programme (EQAP) for laboratories working in the field of haemostasis and thrombosis. The foundation distributes survey materials, accepts participant result submissions, and publishes evaluation reports that enable laboratories to verify the accuracy of coagulation testing. It also sells POCT INR Quality Control kits and programmes for CoaguChek monitors, and hosts an annual educational symposium on thrombosis and haemostasis.

Product overview

ECAT Foundation offers a unified portfolio centered on external quality assessment for thrombosis and haemostasis diagnostics. The core offering is the EQA Programme, which provides international survey-based quality assessment for laboratories. Supporting this are the POCT INR QC Kit and POCT INR QC Programme — point-of-care testing quality control products designed for CoaguChek INR monitors, including certified plasma samples and an online evaluation web application. The EQA Programme focuses on professional laboratory testing, while the POCT products serve both clinical settings and individual patient self-monitoring contexts.

Differentiator

Problem solved

Functional benefit

Brands

• EQA Programme: External Quality Assessment Programme for laboratories in haemostasis and thrombosis
• POCT INR QC Programme

Products and services

• EQA Programme

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered minor.

• Affinity BiologicalsminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• CryopepminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• DiagonminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• George King Bio-MedicalminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• Hyphen BiomedminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• Precision BiologicminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• RocheminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• R2 DiagnosticsminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• SebiaminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• Siemens HealthineersminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• StagominorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• SysmexminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• TechnocloneminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• WerfenminorOthersDiagnostic company listed in the ECAT Diagnostic Corner portal for thrombosis and haemostasis diagnostics.
• Corpus Congress CentreminorOthersConference venue for ECAT Symposium events, located at Willem Einthovenstraat 1, 2342 BH Oegstgeest, Netherlands.
• Hotel Hilton Garden Inn LeidenminorOthersOfficial symposium hotel adjacent to Corpus Congress Centre with special event rates for ECAT attendees.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Regional players

• RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs): RCPAQAP is a major Asia-Pacific EQA provider covering haemostasis and other laboratory disciplines. It is a regional peer with overlapping proficiency testing services, primarily serving laboratories in Australia, New Zealand, and surrounding geographies.
• NASCOLA (North American Specialized Coagulation Laboratory Association): NASCOLA provides specialized proficiency testing focused on coagulation for North American laboratories. It is a regional peer with deep specialization in haemostasis comparable to ECAT, but its geography differs.

Others

• Stago: Stago is a leading manufacturer of haemostasis diagnostic instruments and reagents. While primarily a vendor partner (listed in ECAT's Diagnostic Corner), it also develops internal QC programmes for its own instrumentation, positioning it as both an adjacent industry participant and potential indirect competitor.
• Sysmex Corporation: Sysmex is a major in-vitro diagnostics company with haemostasis product lines. Listed as a partner in ECAT's Diagnostic Corner, it is an industry participant that interacts with the same coagulation laboratory customer base ECAT serves.

Broad incumbents

• CAP (College of American Pathologists) Proficiency Testing: CAP runs one of the world's largest laboratory proficiency testing programmes, including coagulation surveys. It is a broad incumbent with overlapping EQA capabilities for haemostasis, but operates at vastly greater scale and across many disciplines beyond ECAT's focus.
• Bio-Rad Laboratories: Bio-Rad is a major diagnostics manufacturer whose Unity QC programme provides quality control materials and inter-laboratory comparison programmes for clinical laboratories including coagulation. It is a broad incumbent adjacent to EQA services with broader portfolio reach.

Direct peers

• INSTAND e.V. INSTAND is a German non-profit providing EQA programmes across numerous medical laboratory disciplines including haemostasis. It is a direct peer operating on the same membership/subscription model for laboratory quality assessment, with strong European reach.
• UK NEQAS (United Kingdom National External Quality Assessment Service): UK NEQAS is a leading international EQA provider offering proficiency testing programmes across multiple disciplines including haemostasis. It is the most direct peer to ECAT, competing in the same coagulation EQA category with overlapping laboratory customer base across Europe and globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ecat-foundation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECAT Foundation